Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
Crossref DOI link: https://doi.org/10.2337/dc15-2479
Published Online: 2016-06-16
Published Print: 2016-09-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Nauck, Michael
Rizzo, Manfredi
Johnson, Andrew
Bosch-Traberg, Heidrun
Madsen, Jesper
Cariou, Bertrand
Funding for this research was provided by:
Novo Nordisk A/S
Version of Record valid from 2016-08-23